- Home
- 2026
OGI members present at The Annual Clinical Genetic Meeting of The American College of Medical Genetics.
March 13, 2026Eric Pierce gave the keynote address – The Evolution of Gene Therapy: Milestones, Challenges, and Future Directions and Read More
Inas Aboobakar Recognized with The David L. Epstein Clinician-Scientist Research Awardat the American glaucoma Society Annual Meeting in February 2026.
March 13, 2026This award from the Chandler Grant Glaucoma Society honors David L. Epstein, MD—one of the most influential leaders in glaucoma and will provide support for ongoing research examining how glaucoma polygenic risk scores interact with social vulnerability indices to identify individuals at greatest disease risk. They identified a large... Read More
A new review from the OGI IPS research lab discusses prime editing of human pluripotent stem cells.
March 13, 2026Marcela Garita Hernandez and colleagues review progress and report on optimization strategies. Read More
Two new publications from the Bujakowska lab shed light on disorders caused by ASTN1 gene and review options for CRISPR as a therapeutic tool
March 13, 2026Read about our work here: Read More
Inas Aboobakar, MD and colleagues identify a large structural variant associated with primary open-angle glaucoma risk
March 13, 2026The authors leveraged whole genome sequencing data from the hashtag#AllofUsResearchProgram to study genomic variation previously missed with conventional genotyping approaches.
Eric Pierce Discusses IRD Research in in Havard Gazette
February 4, 2026Eric Pierce (Mass Eye and Ear) was featured in the Harvard Gazette discussing from the OGI. The research authored with OGI members Read More
ARVO 2026 Foundation Awards to OGI Researchers
February 4, 2026OGI member recipients of ARVO Foundation awards which provide funding to propel their research and professional growth in recognition of their outstanding contributions to the field of eye and vision research.These Awards will be presented at the 2026 ARVO meeting: Read More
